当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:46.88亿  总市值:48.59亿
流通股本:21.91亿   总股本:22.71亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.31亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益185809.76万元,未分配利润-81021.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产355933.15万元,负债170123.39万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入2,052,008,504.71,432,663,200.48681,168,970.963,107,945,160.6
营业总成本1,937,036,701.961,339,988,733636,373,987.483,045,953,150.67
营业利润260,409,694.6751,371,381.1632,216,202.85-270,085,357.1
利润总额260,197,852.8351,380,819.8332,013,464.93-269,678,552.7
净利润231,061,077.3232,283,048.3221,870,444.7-289,517,719.09
其他综合收益1,361,428.991,640,231.73-714,035.495,021,653.73
综合收益总额232,422,506.3133,923,280.0521,156,409.21-284,496,065.36
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,529,637,539.341,460,639,960.041,738,338,700.121,816,197,553.88
非流动资产合计2,029,693,9392,156,974,626.432,210,063,020.982,257,988,401.13
资产总计3,559,331,478.343,617,614,586.473,948,401,721.14,074,185,955.01
流动负债合计1,669,734,742.291,858,913,339.342,201,855,301.722,336,309,959.62
非流动负债合计31,499,151.7532,659,125.4233,298,792.7734,334,777.99
负债合计1,701,233,894.041,891,572,464.762,235,154,094.492,370,644,737.61
归属于母公司股东权益合计1,789,805,037.641,661,153,081.441,650,582,142.661,631,237,579.41
股东权益合计1,858,097,584.31,726,042,121.711,713,247,626.611,703,541,217.4
负债和股东权益合计3,559,331,478.343,617,614,586.473,948,401,721.14,074,185,955.01
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计2,396,362,568.51,603,357,651.34770,068,919.433,609,859,810.89
经营活动现金流出小计2,089,222,023.951,400,886,902.41686,369,552.283,348,244,203.11
经营活动产生的现金流量净额307,140,544.55202,470,748.9383,699,367.15261,615,607.78
投资活动现金流入小计494,449,262.81345,930,246.9857,198,472.28504,450,255.47
投资活动现金流出小计386,688,634.3303,647,516.932,051,240.2728,333,214.96
投资活动产生的现金流量净额107,760,628.5142,282,730.0825,147,232.08-223,882,959.49
筹资活动现金流入小计1,095,160,0001,095,160,000695,195,0001,660,925,000
筹资活动现金流出小计1,805,985,934.611,597,096,061.35796,453,939.961,873,473,813.27
筹资活动产生的现金流量净额-710,825,934.61-501,936,061.35-101,258,939.96-212,548,813.27
汇率变动对现金及现金等价物的影响1,842,931.272,189,526.22-771,945.1811,924,940.52
现金及现金等价物净增加额-294,081,830.28-254,993,056.126,815,714.09-162,891,224.46
期末现金及现金等价物余额936,539,483.91975,628,258.071,237,435,456.331,230,621,314.19
TOP↑